MedTrace Logo

Standing Desk Converter & Habitual Posture

NCT05970588 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2026-04-29

No results posted yet for this study

Summary

This project will determine the short-term impact of a standing desk converter on: 1) objectively measured physical activity and posture levels, and 2) brain (cognition) and heart (blood pressure regulation) function. The main outcome is habitual activity patterns, assessed by the thigh-worn inclinometer (activPAL). All participants will be equipped with an activPAL and have their cardiovascular and cognitive function assessed at baseline and 4 weeks. Participants in the intervention group will use a standing desk converter for 4 weeks, while the wait-list control group will be encouraged to maintain their regular activity patterns. Researchers will compare the intervention and control groups to see if using the standing desk converter will increase standing time and lower sedentary time, improve cognition, and improve blood pressure regulation.

Conditions

  • Sedentary Time
  • Cognitive Function
  • Blood Pressure Regulation

Interventions

BEHAVIORAL

Standing Promotion Intervention

Participants will be provided with a standing desk converter to set on top of their existing desk for 4 weeks.

Sponsors & Collaborators

  • Olga Theou

    lead OTHER

Principal Investigators

  • Myles W O'Brien, PhD · Department of Medicine and Department of Physiotherapy, Dalhousie University

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-10-01
Primary Completion
2025-02-24
Completion
2025-02-24

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05970588 on ClinicalTrials.gov